Financials
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 30 M28 M28 M29 M27 M26 M 110 M Research & development 123 M101 M122 M139 M141 M121 M 523 M Operating income 105 M103 M122 M8 M142 M114 M 386 M Non-Operating Income, Total 13 M10 M10 M8 M7 M8 M 33 M Interest expense, net of interest capitalized 1 M2 M1 M2 M3 M2 M 8 M Non-Operating Income, excl. Interest Expenses 12 M8 M9 M6 M4 M6 M 25 M Unusual income/expense —————— — Pretax income 92 M93 M112 M0135 M106 M 353 M Equity in earnings —————— — Taxes 01 M0000 0 Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 92 M94 M112 M0135 M106 M 353 M Discontinued operations —————— — Net income 92 M94 M112 M0135 M106 M 353 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 92 M94 M112 M0135 M106 M 353 M Basic earnings per share (Basic EPS) -1-1.07-1.140-1.27-0.88 -3.29 Diluted earnings per share (Diluted EPS) -1-1.07-1.140-1.27-0.88 -3.29 Average basic shares outstanding 91.4 M90.1 M98.4 M106.1 M106.5 M107.4 M 418.4 M Diluted shares outstanding 91.4 M90.1 M98.4 M106.5 M106.5 M107.4 M 418.8 M EBITDA -111 M-109 M-126 M-11 M-145 M-117 M -399 M EBIT -105 M-103 M-122 M-8 M-142 M-114 M -386 M Cost of revenue 000000 0 Other cost of goods sold —————— — Depreciation & amortization (cash flow) -6 M-6 M-4 M-3 M-3 M-3 M -13 M